Clinical, Endoscopic, and Radiological Effectiveness of Ustekinumab in Bio-naïve Versus Bio-experienced Patients With Crohn's Disease: Real-world Experience From a Large Canadian Center.
Inflamm Bowel Dis
; 29(6): 866-874, 2023 06 01.
Article
de En
| MEDLINE
| ID: mdl-35851799
In this large real-world study of patients with Crohn's Disease treated with ustekinumab, we observed high rates of clinical, endoscopic, radiological, and biochemical response and remission rates. Effectiveness was greater in bio-naïve compared with bio-experienced patients.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Maladie de Crohn
/
Ustékinumab
Type d'étude:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limites:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Pays/Région comme sujet:
America do norte
Langue:
En
Journal:
Inflamm Bowel Dis
Sujet du journal:
GASTROENTEROLOGIA
Année:
2023
Type de document:
Article
Pays d'affiliation:
Canada
Pays de publication:
Royaume-Uni